miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development

Journal of Molecular Medicine

Volumn 93, Issue 10, 2015, Pages 1159-1169

  Latreille, Mathieu ^a,b   Herrmanns, Karolin ^a   Renwick, Neil ^c   Tuschl, Thomas ^c   Malecki, Maciej T ^d,e   McCarthy, Mark I ^f,g,h   Owen, Katharine R ^h   Rülicke, Thomas ⁱ   Stoffel, Markus ^a,j  

^a ETH ZURICH   (Switzerland)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c ROCKEFELLER UNIVERSITY   (United States)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h CHURCHILL HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^j UNIVERSITY OF ZURICH   (Switzerland)

more..

Author keywords

Biomarker; Diabetes; MiRNA 375; Pancreatic cells; cell mass

Indexed keywords

GLUCOSE; INSULIN; MICRORNA 375; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; MICRORNA; MIRN375 MICRORNA, HUMAN; MIRN375 MICRORNA, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; GAIN OF FUNCTION MUTATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PHENOTYPE; REGULATORY MECHANISM; AGED; ANALYSIS; ANIMAL; BLOOD; C57BL MOUSE; FEMALE; GENE DOSAGE; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; TRANSGENIC MOUSE; YOUNG ADULT;

ADULT; AGED; ANIMALS; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE DOSAGE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; MIDDLE AGED; YOUNG ADULT;

EID: 84942985712     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1296-9     Document Type: Article

References (46)

1. Pirot P, Cardozo AK, Eizirik DL (2008) Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq Bras Endocrinol Metabol 52:156–165
2. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846
3. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812
4. Garber AJ (2011) Incretin effects on β-cell function, replication, and mass: the human perspective. Diabetes Care 34:S258–S263
5. Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149:515–524
6. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401–1414
7. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226–230
8. Avnit-Sagi T, Vana T, Walker MD (2012) Transcriptional mechanisms controlling miR-375 gene expression in the pancreas. Exp Diabetes Res 2012:891216
9. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, Hornstein E, Walker MD (2009) The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS ONE 4:e5033
10. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, Zavolan M, Stoffel M (2009) miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 106:5813–5818
11. Cortez MA, Calin GA (2009) MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9:703–711
12. Zubakov D, Boersma AW, Choi Y, van Kuijk PF, Wiemer EA, Kayser M (2010) MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med 124:217–226
13. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659
14. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423–433
15. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci 108:5003–5008
16. Li L, Zhu D, Huang L, Zhang J, Bian Z, Chen X, Liu Y, Zhang CY, Zen K (2012) Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS ONE 7:e46957
17. Guay C, Regazzi R (2013) Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 9:513–521
18. Erener S, Mojibian M, Fox JK, Denroche HC, Kieffer TJ (2013) Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. Endocrinology 154:603–608
19. Renwick N, Cekan P, Masry PA, McGeary SE, Miller JB, Hafner M, Li Z, Mihailovic A, Morozov P, Brown M et al (2013) Multicolor microRNA FISH effectively differentiates tumor types. J Clin Invest 123:2694–2702
20. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50:298–301
21. Lee EK, Kim W, Tominaga K, Martindale JL, Yang X, Subaran SS, Carlson OD, Mercken EM, Kulkarni RN, Akamatsu W et al (2012) RNA-binding protein HuD controls insulin translation. Mol Cell 45:826–835
22. Bleisch VR, Mayer J, Dickie MM (1952) Familial diabetes mellitus in mice, associated with insulin resistance, obesity, and hyperplasia of the islands of langerhans. Am J Pathol 28:369–385
23. Hull RL, Kodama K, Utzschneider KM, Carr DB, Prigeon RL, Kahn SE (2005) Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation. Diabetologia 48:1350–1358
24. Latreille M, Hausser J, Stutzer I, Zhang Q, Hastoy B, Gargani S, Kerr-Conte J, Pattou F, Zavolan M, Esguerra JL et al (2014) MicroRNA-7a regulates pancreatic beta cell function. J Clin Invest 124:2722–2735
25. Do OH, Low JT, Gaisano HY, Thorn P (2014) The secretory deficit in islets from db/db mice is mainly due to a loss of responding beta cells. Diabetologia 57:1400–1409
26. Puff R, Dames P, Weise M, Goke B, Seissler J, Parhofer KG, Lechner A (2011) Reduced proliferation and a high apoptotic frequency of pancreatic beta cells contribute to genetically-determined diabetes susceptibility of db/db BKS mice. Horm Metab Res 43:306–311
27. Dalboge LS, Almholt DL, Neerup TS, Vassiliadis E, Vrang N, Pedersen L, Fosgerau K, Jelsing J (2013) Characterisation of age-dependent beta cell dynamics in the male db/db mice. PLoS ONE 8:e82813
28. Pullen TJ, da Silva XG, Kelsey G, Rutter GA (2011) miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 31:3182–3194
29. Mullokandov G, Baccarini A, Ruzo A, Jayaprakash AD, Tung N, Israelow B, Evans MJ, Sachidanandam R, Brown BD (2012) High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 9:840–846
30. Li Z, Karlsson FA, Sandler S (2000) Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. J Endocrinol 165:93–99
31. Hamaguchi K, Utsunomiya N, Takaki R, Yoshimatsu H, Sakata T (2003) Cellular interaction between mouse pancreatic α-cell and β-cell lines: possible contact-dependent inhibition of insulin secretion. Exp Biol Med 228:1227–1233
32. Asplin CM, Paquette TL, Palmer JP (1981) In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest 68:314–318
33. Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH (1984) Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 74:2296–2299
34. Kawamori D, Kurpad AJ, Hu J, Liew CW, Shih JL, Ford EL, Herrera PL, Polonsky KS, McGuinness OP, Kulkarni RN (2009) Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 9:350–361
35. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T, Beissbarth T, Kuner R, Sultmann H (2011) Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128:608–616
36. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70:9798–9807
37. Biton M, Levin A, Slyper M, Alkalay I, Horwitz E, Mor H, Kredo-Russo S, Avnit-Sagi T, Cojocaru G, Zreik F et al (2011) Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat Immunol 12:239–246
38. Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G (2004) Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 65:259–265
39. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y (2003) The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14:1480–1486
40. Neal CS, Michael MZ, Pimlott LK, TYong TY, Li JYZ, Gleadle JM (2011) Circulating microRNA expression is reduced in chronic kidney disease. Nephrol Dial Transplant 26:3794–3802
41. Higuchi C, Nakatsuka A, Eguchi J, Teshigawara S, Kanzaki M, Katayama A, Yamaguchi S, Takahashi N, Murakami K, Daisuke Ogawa D et al (2015) Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. Metabolism 64:489–497
42. Szeto CC, Ching-Ha KB, Ka-Bik L, Mac-Moune LF, Cheung-Lung CP, Gang W, Kai-Ming C, Kam-Tao LP (2012) Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis Markers 33:137–144
43. Nielsen LB, Wang C, Sorensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F et al (2012) Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res 2012:896362
44. Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251–261
45. Gepts W, Lecompte PM (1981) The pancreatic islets in diabetes. Am J Med 70:105–115
46. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D et al (1994) Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 153:1360–1377